| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.6M | +31.5% |
| R&D Expense | $59.7M | -19.5% |
| SG&A Expense | $22.1M | -25.0% |
| Operating Income | -$62.2M | +29.9% |
| Net Income | -$60.5M | +30.4% |
| EPS (Basic) | -$1.46 | +43.6% |
| EPS (Diluted) | -$1.46 | +43.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.9M | -76.9% |
| Current Assets | $23.8M | -70.4% |
| Total Assets | $30.5M | -66.0% |
| Current Liabilities | $16.1M | +0.9% |
| Total Liabilities | $58.4M | -7.4% |
| Stockholders' Equity | -$27.9M | -205.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.9M | +26.2% |
| Capital Expenditures | $123K | -89.1% |
| Investing Cash Flow | -$123K | -100.2% |
| Financing Cash Flow | $344K | -99.4% |
| Free Cash Flow | -$60.0M | +27.1% |